References
- Ahmad F, Anwar F, Hira S. 2016. Review on medicinal importance of Fabaceae family. Pharmacologyv. 3:151–156.
- Andersen OM, Markham KR. 2005. Flavonoids: chemistry, biochemistry and applications. CRC Press. Boca Raton, FL.
- Andrade ALP, Miotto STS, Santos EP. 2009. A subfamília Faboidea (Fabaceae Lindl.) no parque estadual do Guartelá, Paraná, Brasil. Hoehnea. 36(4):737–768.
- Arnous AH, Santos AS, Beinner RC. 2005. Plantas medicinais de uso caseiro-conhecimento popular e interesse por cultivo comunitário. Revista Espaço Para a Saúde. 6(2):1–6.
- Kumamoto H, Matsubara Y, Iizuka Y, Okamoto K, Yokoi K. 1986. Structures and hypotensive effect of flavonoid glycosides in Unshiu peeling. II. J Jpn Oil Chem Soc. 35(5):379–381.
- Lee DY, Lyu HN, Kwak HY, Jung L, Lee YH, Kim DK, Chung IS, Kim SH, Baek NI. 2007. Isolation of Flavonoids from the fruits of Cornus kousa Burg. J Appl Biol Chem. 50(3):144–147.
- Madjid OA, Sanni A, Lagnika L. 2020. Chemical diversity and pharmacological properties of genus Acacia. Asian J Appl Sci. 13(2):40–59.
- Malinovsky JM, Le Normand L, Lepage JY, Malinge M, Cozian A, Pinaud M, Buzelin JM. 1998. The effects of intravenous opioids and ketoprofen in humans. Anesth Analg. 87(2):456–461.
- Nasr C, Haag-Berrurier M, Lobstein-Guth A, Anton R. 1986. Kaempferol coumaroyl glucorhamnoside from Ginkgo biloba. Phytochemistry. 25(3):770–771.
- Newman DJ, Cragg GM. 2016. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 79(3):629–661.
- Nicácio KJ, Ferreira MS, Katchborian-Neto A, Costa ML, Murgu M, Dias DF, Soares MG, Chagas-Paula DA. 2022. Anti-inflammatory markers of hops cultivars (Humulus lupulus L.) evaluated by untargeted metabolomics strategy. Chemistry & Biodiversity. 19(4):1612–1872.
- Noldin VF, Isaias DB, Cechinel Filho V. 2006. Gênero Calophyllum: importância química e farmacológica. Quím Nova. 29(3):549–554.
- Parente L. 2001. Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? J Rheumatol. 28:2375–23 82.
- Riaz A, Rasul A, Hussain G, Zahoor MK, Jabeen F, Subhani Z, Younis T, Ali M, Sarfraz I, Selamoglu Z. 2018. Astragalin: a bioactive phytochemical with potential therapeutic activities. Advances in Pharmacological Sciences. 2018:1–15.
- Rosa W, Domingos OS, Salem PP, Caldas IS, Murgu M, Lago JHG, Sartorelli P, Dias DF, Chagas-Paula DA, Soares MG. 2021. In vivo anti-inflammatory activity of Fabaceae species extracts screened by a new ex vivo assay using human whole blood. Phytochem Anal. 32(5):859–883.
- Santos MF, Alcântara BG, dos R. Feliciano C, Silva AF, Maiolini TC, Neto AK, Murgu M, de Paula DAC, Soares MG. 2019. New bicyclic [3.2. 1] octane neolignans derivatives from Aniba firmula with potent in vivo anti-inflammatory activity on account of dual inhibition of PGE2 production and cell recruitment. Phytochem Lett. 30:31–37.
- Santos MFC, Feliciano CR, Neto AK, Paula DAC, Soares MG. 2023. New bicyclic [3.2.1] octane neolignan derivative from Aniba firmula. Nat Prod Res. 37(7):1217–1220.
- Silva MC, Carvalho JCT. 2004. Plantas medicinais. In Carvalho JCT. Fitoterápicos, anti-inflamatórios: aspectos químicos, farmacológicos e aplicações terapêuticas. São Paulo: tecmedd, v. 1, p. 480.
- Zanin JLB, de Carvalho BA, Martineli PS, dos Santos MH, Lago JHG, Sartorelli P, Viegas C, Jr, Soares MG. 2012. The genus Caesalpinia L. (Caesalpiniaceae): phytochemical and pharmacological characteristics. Molecules. 17(7):7887–7902.